280 related articles for article (PubMed ID: 32609900)
1. MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma.
Wei X; Zhao L; Ren R; Ji F; Xue S; Zhang J; Liu Z; Ma Z; Wang XW; Wong L; Liu N; Shi J; Guo X; Roessler S; Zheng X; Ji J
Hepatology; 2021 Apr; 73(4):1381-1398. PubMed ID: 32609900
[TBL] [Abstract][Full Text] [Related]
2. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
Song Y; Xing H; Zhou L; Zhang N; Yang M
Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
[TBL] [Abstract][Full Text] [Related]
3. PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
Martin SP; Fako V; Dang H; Dominguez DA; Khatib S; Ma L; Wang H; Zheng W; Wang XW
J Exp Clin Cancer Res; 2020 Jun; 39(1):99. PubMed ID: 32487192
[TBL] [Abstract][Full Text] [Related]
4. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.
Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y
PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of miR-1268a expression and its beneficial effects for post-operative adjuvant transarterial chemoembolization in hepatocellular carcinoma.
Lu YL; Yao JG; Huang XY; Wang C; Wu XM; Xia Q; Long XD
Sci Rep; 2016 Oct; 6():36104. PubMed ID: 27796321
[TBL] [Abstract][Full Text] [Related]
6. Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
Kim SS; Nam JS; Cho HJ; Won JH; Kim JW; Ji JH; Yang MJ; Park JH; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
J Gastroenterol Hepatol; 2017 Jan; 32(1):199-207. PubMed ID: 27194671
[TBL] [Abstract][Full Text] [Related]
7. Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization.
Fako V; Martin SP; Pomyen Y; Budhu A; Chaisaingmongkol J; Franck S; Lee JM; Ng IO; Cheung TT; Wei X; Liu N; Ji J; Zhao L; Liu Z; Jia HL; Tang ZY; Qin LX; Kloeckner R; Marquardt J; Greten T; Wang XW
Int J Biol Sci; 2019; 15(12):2654-2663. PubMed ID: 31754337
[TBL] [Abstract][Full Text] [Related]
8. miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression.
Chen M; Wu L; Tu J; Zhao Z; Fan X; Mao J; Weng Q; Wu X; Huang L; Xu M; Ji J
EBioMedicine; 2018 Sep; 35():142-154. PubMed ID: 30111512
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA MIAT knockdown potentiates the therapeutic effect of transcatheter arterial embolization in liver cancer by regulating the miR‑203a/HIF‑1α axis.
Liu J; Cao G; Liu J; Zhao X; Cao H
Oncol Rep; 2020 Aug; 44(2):722-734. PubMed ID: 32468055
[TBL] [Abstract][Full Text] [Related]
10. Expression changes of miRNA-203 before and after transcatheter arterial chemoembolization in hepatocellular carcinoma patients and its clinical significance.
Li X; Li S; Xing X; Wang L
J BUON; 2021; 26(2):429-434. PubMed ID: 34076989
[TBL] [Abstract][Full Text] [Related]
11. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
12. Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma.
Chong CC; Cheung ST; Cheung YS; Chan AW; Chan SL; Yu SC; Lai PB
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):524-530. PubMed ID: 30413348
[TBL] [Abstract][Full Text] [Related]
13. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization.
Ali HEA; Emam AA; Zeeneldin AA; Srour R; Tabashy R; El-Desouky ED; Abd Elmageed ZY; Abdel-Wahab AA
Clin Biochem; 2019 Mar; 65():45-52. PubMed ID: 30653948
[TBL] [Abstract][Full Text] [Related]
15. Circulating MiRNA-373 as a Predictor of Response to Super-selective Transarterial Chemoembolization Bridging Therapy in Hepatocellular Carcinoma Patients Awaiting Liver Transplantation.
Tork ASE; Kamel AAF; Zaki MA; Abo El-Wafa RAH; El-Assar OS; Ibrahim Abdelkarem OA
Asian Pac J Cancer Prev; 2023 Jan; 24(1):291-299. PubMed ID: 36708579
[TBL] [Abstract][Full Text] [Related]
16. Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients.
E Abdelaziz H; El-Guendy N; Radwan EM; Sharawi SK; El-Houseini ME; Abdel-Wahab AA
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4125-4135. PubMed ID: 36579994
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma.
Li XS; Wang JH; Yang XZ; Ma L; Shi YX; Song Y; Jiang P; Gao S; Dong Y; Lin JR; Jin C
Aging (Albany NY); 2019 May; 11(10):2998-3011. PubMed ID: 31136302
[TBL] [Abstract][Full Text] [Related]
19. miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma.
Liu J; Yan J; Zhou C; Ma Q; Jin Q; Yang Z
Tumour Biol; 2015 Jan; 36(1):219-25. PubMed ID: 25230788
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.
Lin ZH; Jiang JR; Ma XK; Chen J; Li HP; Li X; Wu XY; Huang MS; Lin Q
Clin Exp Med; 2021 Feb; 21(1):109-120. PubMed ID: 33037574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
